However, treatments with EPC secretome has been shown to suppress NF-κB transcriptional activity, leading to enhanced neovascularization invivo following stroke and myocardial ischemia and restoring BBB integrity invitro [63–65]. The gene discussed is NFKB1; the disease is stroke disorder.